DENVER, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CLINICAL AND PATIENT EDUCATORS ASSOCIATION, founded in 2010, is a small nonprofit in the Health Care sector that reported $588K in total revenue in fiscal year 2023. Revenue surged 26% from the prior year, signaling strong growth momentum. Expenses of $542K left a modest 8% surplus.
DEVELOP QUALITY, INNOVATIVE EDUCATION FOR HEALTHCARE PRACTITIONERS AND THE PATIENT COMMUNITIES THEY SERVE. THE ORGANIZATION IDENTIFIED A NEED FOR DESIGNING EDUCATION AIMED AT ADDRESSING PRACTICE GAPS AMONG PRIMARY AND SPECIALTY CARE PRACTITIONERS AND HEALTHCARE INFORMATION KNOWLEDGE GAPS WITHIN THEIR RESPECTIVE PATIENT POPULATIONS. THE ORGANIZATION'S EDUCATION PROGRAMS ARE DESIGNED TO IMPROVE PRACTITIONER DIAGNOSIS AND TREATMENT COMPETENCE, AS WELL AS HELP PATIENTS ENJOY HEALTHIER AND HAPPIER LIVES AFTER BEING DIAGNOSED WITH A DISEASE OR OTHER HEALTH-RELATED ISSUE. THE ORGANIZATION IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION TO CERTIFY CONTINUING MEDICAL EDUCATION (CME) PROGRAMS FOR PHYSICIANS.
COLE EYE INSTITUTE IMAGING SUMMIT WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN SEATTLE, WA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) RECOGNIZE NEW IMAGING FINDINGS OF RETINAL DISEASES...
COLE EYE INSTITUTE IMAGING SUMMIT WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN SEATTLE, WA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) RECOGNIZE NEW IMAGING FINDINGS OF RETINAL DISEASES, (2) IDENTIFY IMAGING TO DETECT EARLY RETINAL DISEASE, (3) DISCUSS ROLE OF FUNCTIONAL IMAGING TECHNIQUES, (4) DESCRIBE HOW AI-BASED IMAGING CAN HELP DIAGNOSE AND MANAGE PATIENTS WITH RETINAL DISEASES, (5) EXPLAIN HOW IMAGING IS USED TO EVALUATE CLINICAL TRIAL OUTCOMES, AND (6) REVIEW HOW TO OPTIMIZE THE USE OF IMAGING IN CLINICAL PRACTICE. THE ORGANIZATION PROVIDED 3.25 AMA PRA CATEGORY 1 CREDITS FOR THE ACTIVITY.
COLE EYE INSTITUTE RETINA SUMMIT WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN NEW ORLEANS, LA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) REVIEW THE CURRENT RECOMMENDATIONS AND EMERGING...
COLE EYE INSTITUTE RETINA SUMMIT WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN NEW ORLEANS, LA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) REVIEW THE CURRENT RECOMMENDATIONS AND EMERGING STRATEGIES FOR THE DIAGNOSIS OF RETINAL DISEASES, (2) EVALUATE THE EMERGING CLINICAL TRIAL DATA AND BEST PRACTICES FOR THE TREATMENT OF RETINAL DISEASES, AND (3) IDENTIFY HOW NEW AND EMERGING DIAGNOSTIC TECHNIQUES AND THERAPIES CAN BE INCORPORATED INTO THE MANAGEMENT OF PATIENTS WITH RETINAL DISEASE. THE ORGANIZATION PROVIDED 3.5 AMA PRA CATEGORY 1 CREDITS FOR THE ACTIVITY.
ADVANCES IN PEDIATRIC RETINA WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN SANTA CLARA, CA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) DISCUSS TREATMENT STRATEGIES THAT OPTIMIZE VISION IN...
ADVANCES IN PEDIATRIC RETINA WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN SANTA CLARA, CA. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) DISCUSS TREATMENT STRATEGIES THAT OPTIMIZE VISION IN DEVELOPING INFANTS AND CHILDREN, (2) DEFINE DIFFERENT MANIFESTATIONS OF COMMON PEDIATRIC RETINAL CONDITIONS, (3) EVALUATE NEW THERAPIES AND TECHNOLOGIES FOR USE IN CLINICAL PRACTICE, (4) DISCUSS GENETIC CONDITIONS THAT AFFECT VISION IN CHILDREN, (5) DISCUSS SURGICAL TECHNIQUES IN CHILDREN AND HOW THEY DIFFER FROM ADULT RETINA SURGERY, (6) IDENTIFY GENE-THERAPY TREATMENT STRATEGIES FOR REPLACING MUTATION-BEARING GENES AND PRODUCING THERAPEUTIC PROTEINS, AND (7) UNDERSTAND CLINICAL TRIAL RESULTS EVALUATING INVESTIGATIONAL GENE THERAPIES FOR INHERITED RETINAL DISEASES (IRDS). THE ORGANIZATION PROVIDED 17.25 AMA PRA CATEGORY 1 CREDITS FOR THE ACTIVITY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $587,953 | $467,713 | +0.3% |
| Expenses | $541,919 | $407,150 | +0.3% |
| Net Income | $46,034 | $60,563 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| THOMAS RAMETTA | PRESIDENT | 2.00 |
Officer
Director
|
$0 | $27,209 | $1,530,352 |
| DARLYNE BAILEY | CHAIR OF THE BOARD | 3.00 |
Officer
Director
|
$0 | $0 | $70,000 |
| THEODORE L POLIN | VICE CHAIR OF THE BOARD (THRU 12/23) | 2.00 |
Officer
Director
|
$0 | $0 | $60,000 |
| HUGH CAMPBELL | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| KAREN MINCEY | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| SAUNDRA WALL WILLIAMS | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| STEPHEN BURGHARDT | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| CHRISTOPHER HAWK MD | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| SHEILA MCDEVITT | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $50,000 |
| TERENCE BYRD | BOARD MEMBER (BEG 1/23) | 2.00 |
Director
|
$0 | $0 | $47,043 |
| ALEXANDRA SCHAFFRATH | TREASURER | 2.00 |
Officer
|
$0 | $31,372 | $826,441 |
| NICOLE M ANZUONI | SECRETARY | 2.00 |
Officer
|
$0 | $22,134 | $799,512 |
| JEFFREY B REESE | ASSISTANT CORPORATE SECRETARY | 2.00 |
Officer
|
$0 | $2,867 | $209,773 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $587,953 | $541,919 | $300,054 | $46,034 |
| 2022 | $467,713 | $407,150 | $248,701 | $60,563 |
| 2021 | $195,000 | $184,983 | $82,888 | $10,017 |
| 2020 | $170,330 | $137,624 | $30,031 | $32,706 |
| 2019 | $334,191 | $409,060 | $55,906 | $-74,869 |
| 2018 | $429,038 | $373,554 | $84,504 | $55,484 |
Compare CLINICAL AND PATIENT EDUCATORS ASSOCIATION with other nonprofits in Colorado and across the country.